Trial · NCT03100058
Adverse events3,610
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,610
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | LIK066 2.5 mg qd (Epoch 3)/25 mg qd (Epoch 4) | 0 | 38 | |
| other | Anaemia | Blood and lymphatic system disorders | LIK066 10 mg qd/25 mg qd | 0 | 38 | |
| other | Anaemia | Blood and lymphatic system disorders | LIK066 50 mg qd/25 mg qd | 0 | 38 | |
| other | Anaemia | Blood and lymphatic system disorders | LIK066 150 mg qd/25 mg qd | 0 | 77 | |
| other | Anaemia | Blood and lymphatic system disorders | LIK066 2.5 mg Bid/35 mg qd | 1 | 38 | |
| other | Anaemia | Blood and lymphatic system disorders | LIK066 5 mg Bid/35 mg qd | 0 | 39 | |
| other | Anaemia | Blood and lymphatic system disorders | LIK066 25 mg Bid/35 mg qd | 0 | 38 | |
| other | Anaemia | Blood and lymphatic system disorders | LIK066 50 mg Bid/35 mg qd | 0 | 76 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo/LIK066 25 mg qd (Epoch 4) | 1 | 40 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo/Placebo | 0 | 38 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | LIK066 2.5 mg qd (Epoch 3)/25 mg qd (Epoch 4) | 0 | 38 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | LIK066 10 mg qd/25 mg qd | 0 | 38 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | LIK066 50 mg qd/25 mg qd | 0 | 38 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | LIK066 150 mg qd/25 mg qd | 0 | 77 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | LIK066 2.5 mg Bid/35 mg qd | 0 | 38 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | LIK066 5 mg Bid/35 mg qd | 0 | 39 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | LIK066 25 mg Bid/35 mg qd | 0 | 38 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | LIK066 50 mg Bid/35 mg qd | 0 | 76 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Placebo/LIK066 25 mg qd (Epoch 4) | 0 | 40 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Placebo/Placebo | 1 | 38 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03100058/events